• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia.

作者信息

Fryauff D J, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, Kain K C, Bangs M J, Richie T L, Baird J K

机构信息

U.S. Naval Medical Research Unit No. 2, Jakarta, Indonesia.

出版信息

Am J Trop Med Hyg. 1998 Oct;59(4):513-8. doi: 10.4269/ajtmh.1998.59.513.

DOI:10.4269/ajtmh.1998.59.513
PMID:9790420
Abstract

Malariometric surveys were conducted during July 1996 in native Dayak villages and predominantly Javanese transmigration settlements in Ketapang district of West Kalimantan, Indonesia. Malaria prevalence ranged from 0.9% to 2.7% in Dayak villages and from 1% to 20% in the transmigration settlements. Plasmodium falciparum accounted for 67% of the cases among Dayaks but P. vivax was dominant among transmigrants, accounting for more than 72% of the infections. Chloroquine sensitivity/resistance was assessed by 28-day in vivo testing of uncomplicated malaria infections and measurement of chloroquine blood levels in cases where parasitemias reappeared within the 28-day test period. Resistance was based on the appearance of asexual parasites against chloroquine plus desethylchloroquine levels exceeding the minimally effective whole blood concentrations proposed for sensitive parasite strains (P. vivax, 100 ng/ml; P. falciparum, 200 ng/ml). All parasitemias cleared initially within four days of beginning supervised chloroquine therapy (25 mg base/kg over a 48-hr period), but asexual parasites reappeared within 28 days in 27 of 52 P. vivax and three of 12 P. falciparum cases. Chloroquine blood levels at the time of recurrent parasitemias revealed resistance in 12 of the 27 P. vivax cases and in one of the three P. falciparum cases. Genotypes of nine of the 12 recurrent P. vivax isolates matched with their primary isolates and ruled out reinfection. These findings establish the presence of chloroquine-resistant P. vivax on the island of Borneo. The pattern of malaria and the high frequency of chloroquine resistance by P. vivax at the West Kalimantan location may relate to demographic, ecologic, agricultural, and socioeconomic changes associated with transmigration.

摘要

相似文献

1
Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia.
Am J Trop Med Hyg. 1998 Oct;59(4):513-8. doi: 10.4269/ajtmh.1998.59.513.
2
Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.印度尼西亚龙目岛恶性疟原虫和间日疟原虫对氯喹的体内敏感性调查。
Am J Trop Med Hyg. 1997 Feb;56(2):241-4. doi: 10.4269/ajtmh.1997.56.241.
3
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.来自印度尼西亚伊里安查亚省西北部偏远的加格岛的恶性疟原虫和间日疟原虫对抗疟药的体内反应。
Am J Trop Med Hyg. 1999 Apr;60(4):542-6. doi: 10.4269/ajtmh.1999.60.542.
4
In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.印度尼西亚伊里安查亚省纳比雷间日疟原虫和恶性疟原虫对氯喹的体内抗药性
Am J Trop Med Hyg. 1997 Jun;56(6):627-31. doi: 10.4269/ajtmh.1997.56.627.
5
Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.评价印度尼西亚苏门答腊南部地区氯喹治疗间日疟和恶性疟的效果。
Malar J. 2010 Feb 12;9:52. doi: 10.1186/1475-2875-9-52.
6
Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia.印度尼西亚东部小巽他群岛阿洛岛间日疟原虫对氯喹的耐药性
Am J Trop Med Hyg. 2009 Aug;81(2):338-42.
7
The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia.印度尼西亚北苏门答腊尼亚斯岛人类疟疾的药物敏感性及传播动态
Ann Trop Med Parasitol. 2002 Jul;96(5):447-62. doi: 10.1179/000349802125001249.
8
Malaria situation in several villages around Timika, south central Irian Jaya, Indonesia.印度尼西亚伊里安查亚省中南部蒂米卡周边几个村庄的疟疾疫情。
Southeast Asian J Trop Med Public Health. 1998 Jun;29(2):228-35.
9
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
10
Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping.
Am J Trop Med Hyg. 2000 Jun;62(6):693-7. doi: 10.4269/ajtmh.2000.62.693.

引用本文的文献

1
Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023.2023 年 1 月至 5 月期间在泰国北碧府的间日疟原虫分离株中发现的耐药性标记物。
PLoS One. 2024 Jul 5;19(7):e0304337. doi: 10.1371/journal.pone.0304337. eCollection 2024.
2
The history and current epidemiology of malaria in Kalimantan, Indonesia.印度尼西亚加里曼丹的疟疾历史和当前流行病学。
Malar J. 2022 Nov 14;21(1):327. doi: 10.1186/s12936-022-04366-5.
3
Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
葡萄糖-6-磷酸脱氢酶变异在印度尼西亚东帝汶中南部疟疾流行区的流行情况。
Am J Trop Med Hyg. 2020 Aug;103(2):760-766. doi: 10.4269/ajtmh.19-0780. Epub 2020 Jun 25.
4
Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia.氯喹治疗埃塞俄比亚中南部古拉加地区间日疟原虫感染病例的疗效。
BMC Infect Dis. 2019 May 14;19(1):413. doi: 10.1186/s12879-019-4055-7.
5
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
6
Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Vivapain-3 (VP-3).通过药效团建模、对接和分子动力学模拟发现针对Vivapain-3(VP-3)的小分子。
Heliyon. 2018 May 8;4(5):e00612. doi: 10.1016/j.heliyon.2018.e00612. eCollection 2018 May.
7
Two clusters of Plasmodium knowlesi cases in a malaria elimination area, Sabang Municipality, Aceh, Indonesia.印度尼西亚亚齐省萨邦市消除疟疾地区的两群 knowlesi 疟疾病例。
Malar J. 2018 May 2;17(1):186. doi: 10.1186/s12936-018-2334-1.
8
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.青蒿琥酯-甲氟喹治疗马来西亚氯喹耐药间日疟原虫疟疾的疗效:一项开放标签、随机、对照试验。
Clin Infect Dis. 2016 Jun 1;62(11):1403-1411. doi: 10.1093/cid/ciw121. Epub 2016 Apr 22.
9
Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia.氯喹对埃塞俄比亚南部霍萨纳医疗中心门诊间日疟原虫疟疾患者的治疗效果
Malar J. 2015 Nov 17;14:458. doi: 10.1186/s12936-015-0983-x.
10
Chloroquine remains effective for treating Plasmodium vivax malaria in Pursat province, Western Cambodia.氯喹对柬埔寨西部菩萨省间日疟原虫疟疾仍有治疗效果。
Antimicrob Agents Chemother. 2014 Oct;58(10):6270-2. doi: 10.1128/AAC.03026-14. Epub 2014 Jul 21.